China SXT Pharmaceuticals Inc (SXTC)
0.43
-0.03
(-6.54%)
USD |
NASDAQ |
Nov 14, 16:00
0.43
0.00 (0.00%)
After-Hours: 20:00
China SXT Pharmaceuticals Enterprise Value: -8.059M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | -8.059M |
| November 12, 2024 | -8.025M |
| November 11, 2024 | -7.969M |
| November 08, 2024 | -7.962M |
| November 07, 2024 | -8.008M |
| November 06, 2024 | -8.049M |
| November 05, 2024 | -7.903M |
| November 04, 2024 | -7.994M |
| November 01, 2024 | -7.816M |
| October 31, 2024 | -7.716M |
| October 30, 2024 | -7.651M |
| October 29, 2024 | -7.526M |
| October 28, 2024 | -7.608M |
| October 25, 2024 | -7.66M |
| October 24, 2024 | -7.556M |
| October 23, 2024 | -7.535M |
| October 22, 2024 | -7.340M |
| October 21, 2024 | -7.297M |
| October 18, 2024 | -7.468M |
| October 17, 2024 | -7.389M |
| October 16, 2024 | -7.570M |
| October 15, 2024 | -7.460M |
| October 14, 2024 | -7.707M |
| October 11, 2024 | -7.677M |
| October 10, 2024 | -7.681M |
| Date | Value |
|---|---|
| October 09, 2024 | -7.712M |
| October 08, 2024 | -7.400M |
| October 07, 2024 | -7.141M |
| October 04, 2024 | -7.159M |
| October 03, 2024 | -7.112M |
| October 02, 2024 | -6.892M |
| October 01, 2024 | -7.260M |
| September 30, 2024 | -7.122M |
| September 27, 2024 | -7.427M |
| September 26, 2024 | -7.373M |
| September 25, 2024 | -7.562M |
| September 24, 2024 | -7.417M |
| September 23, 2024 | -7.514M |
| September 20, 2024 | -7.500M |
| September 19, 2024 | -7.396M |
| September 18, 2024 | -7.260M |
| September 17, 2024 | -7.510M |
| September 16, 2024 | -7.573M |
| September 13, 2024 | -7.344M |
| September 12, 2024 | -7.364M |
| September 11, 2024 | -7.507M |
| September 10, 2024 | -7.697M |
| September 09, 2024 | -7.730M |
| September 06, 2024 | -7.667M |
| September 05, 2024 | -7.615M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-12.32M
Minimum
Aug 31 2023
84.43M
Maximum
Feb 16 2021
3.432M
Average
1.172M
Median
Oct 03 2022
Enterprise Value Benchmarks
| Sinovac Biotech Ltd | -6.942B |
| CASI Pharmaceuticals Inc | 91.55M |
| Zai Lab Ltd | 2.423B |
| Adagene Inc | 29.78M |
| LakeShore Biopharma Co Ltd | -- |
Enterprise Value Related Metrics
| Earnings Yield | -3.81K% |
| Normalized Earnings Yield | -3805.98 |